Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page
- ChecktodayChange DetectedThe page continues to display a 403 Forbidden error instead of the study record. The footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoChange DetectedA site-wide notice announces updates and FAQs about NIH websites and a federal shift from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check14 days agoChange DetectedThe site revision label in the footer changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details. The page displays the site header and a minimal error message, indicating access is blocked.SummaryDifference17%

- Check49 days agoChange DetectedA new publication citation was added under Publications, listing a study on sexual function with adjunctive lumateperone in patients with Major Depressive Disorder.SummaryDifference0.0%

Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.